These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25610351)

  • 1. Cutaneous drug reactions in children: a multicentric study.
    Dilek N; Özkol HU; Akbaş A; Kılınç F; Dilek AR; Saral Y; Metin A; Çalka Ö
    Postepy Dermatol Alergol; 2014 Dec; 31(6):368-71. PubMed ID: 25610351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and the skin: A concise review of cutaneous adverse drug reactions.
    Del Pozzo-Magaña BR; Liy-Wong C
    Br J Clin Pharmacol; 2022 Aug; ():. PubMed ID: 35974692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
    Turk BG; Gunaydin A; Ertam I; Ozturk G
    Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.
    Jha N; Alexander E; Kanish B; Badyal DK
    Indian Dermatol Online J; 2018; 9(5):299-303. PubMed ID: 30258795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
    Sharma R; Dogra D; Dogra N
    Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
    Sinha S; Kar C; Das S; Dutta A; De A
    Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
    Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
    Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India.
    Rana S; Gupta K; Agarwal N; Ahamed ANM
    Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey.
    Akpinar F; Dervis E
    Indian J Dermatol; 2012 May; 57(3):194-8. PubMed ID: 22707770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous adverse drug reactions].
    Lebrun-Vignes B; Valeyrie-Allanore L
    Rev Med Interne; 2015 Apr; 36(4):256-70. PubMed ID: 25458866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
    Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
    Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
    Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
    JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending Tertiary Care Hospital.
    Doshi K; Yegnanarayan R; Gokhale N
    Curr Drug Saf; 2016 Jul; ():. PubMed ID: 27457767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.